Skip to content

To compare the effect of oliceridine and sufentanil on the postoperative recovery quality of patients undergoing laparoscopic cholecystectomy during the day

To compare the effect of oliceridine and sufentanil on the postoperative recovery quality of patients undergoing laparoscopic cholecystectomy during the day

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095986
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder stones, cholecystitis, gallbladder polyps, cholelithiasis

Interventions

Group O:Anesthesia induction : intravenous injection of midazolam 2mg, propofol 2mg / kg, oliceridine 0.06mg / kg , rocuronium 0.6mg / kg Anesthesia maintenance : Remifentanil 4 ~ 8ug / ( kg /h ) and
Group S:Anesthesia induction : intravenous injection of midazolam 2 mg, propofol 2 mg / kg, sufentanil 0.3 µg / kg and rocuronium 0.6 mg / kg Anesthesia maintenance : Remifentanil 4 ~ 8ug / ( kg/ h )

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2.ASA classification of ?-?; 3.BMI: 18-30kg/m^2 4.Patients scheduled for laparoscopic cholecystectomy day surgery under general anesthesia; 5.Subjects voluntarily participated and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Diseases of the nervous or mental system; 2.Serious abnormalities of liver and kidney function; 3.chronic pain; 4.long-term use of analgesic, sedative, antipsychotic drugs; 5. those who have participated in any clinical trial as a subject within 3 months prior to enrollment; 6. other conditions judged by the investigator to be unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-15 ( QoR-15 ) questionnaire scores at 24 hours after surgery.;

Secondary

MeasureTime frame
Systolic pressure(SBP);Diastolic blood pressure(DBP);Mean arterial pressure (MAP);SPO2;Heart rate(HR);Extubation time;Awakening time ;The incidence of adverse events related to analgesia (nausea, vomiting, respiratory depression, restlessness during awakening);Overall patient satisfaction score within 24 hours after surgery;Overall satisfaction rating of surgeons;The occurrence of major postoperative complications(e.g. lung infection);Numerical Rating Scale, NRS;Quality of Recovery-15 ( QoR-15 ) questionnaire scores at 72 hours after surgery.;Damage Index Score;hospitalization time;

Countries

China

Contacts

Public ContactXiaohua Zou

Affiliated Hospital of Guizhou Medical University

562931613@qq.com+86 138 0941 6036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026